Teva (TEVA) Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries, announced the presentation of a patient and healthcare professional (HCP) attitudes and experiences survey study ...

Teva's long haul to a turnaround of its business has been dealt a blow by the FDA, which has just declined to approve the company's long-acting formulation of schizophrenia drug risperidone.

Armed with positive data from a phase 2b trial, Teva and Sanofi have decided to push their anti-TL1A antibody duvakitug into a phase 3 programme in inflammatory bowel disease (IBD). The results of ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

30 days Prescribing information Latanoprost 0.005% ophthalmic solution Xalatan (Pharmacia and Upjohn) 6 wk Prescribing information Lopinavir/ritonavir capsules Kaletra capsules (Abbott ...

1 Day TEVA -7.07% DJIA -5.50% S&P 500 -5.97% Health Care/Life Sciences 0.87% ...

Nasdaq provides visual representation of analyst expected earnings growth. Read our earnings report guide before you consider the forecast information when making investment decisions. Visit the ...